Gayatri Bioorganics Limited Schedules Board Meeting for April 15, 2026 to Consider Share Capital Reduction Scheme

Gayatri bioorganics Limited has announced a board meeting scheduled for April 15, 2026, to deliberate on significant corporate restructuring matters. The meeting will be held at the company's registered office in accordance with regulatory requirements.

Board Meeting Agenda

The board meeting has been convened under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The primary agenda items include:

Agenda Item:	Details
Primary Matter:	Scheme of Reduction of Share Capital
Additional Items:	Any other matter with permission of chair
Meeting Date:	April 15, 2026
Venue:	Registered office of the company

Trading Window Restrictions

The company has implemented trading restrictions in compliance with insider trading regulations. The trading window for dealing in the company's securities has been closed from April 1, 2026, and will remain closed until 48 hours after the declaration of audited financial results for the quarter and financial year ended March 31, 2026.

These restrictions apply to:

All designated persons
Their immediate relatives
All connected persons covered under the company's Code of Conduct

The closure is in accordance with the company's Code for regulating, monitoring and reporting of trading by insiders, framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Corporate Information

The notification was signed by Sreedhara Reddy Kanaparthy, Whole-time Director (DIN: 09608890), on April 8, 2026. The company is headquartered at TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad, Telangana, and operates under CIN L24110TG1991PLC013512.

This development represents a significant corporate action that requires board approval and regulatory compliance, with the scheme of reduction of share capital being the primary focus of the upcoming meeting.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+9.18%	+27.94%	+47.98%	+48.72%	+156.80%	+180.47%

Gayatri BioOrganics Limited has issued a formal clarification to BSE Limited regarding recent movement in its share price, confirming that no price-sensitive events or extraordinary developments have occurred within the company that would account for the price fluctuation.

Regulatory Response to Exchange Inquiry

The clarification came in response to BSE's inquiry dated March 13, 2026, regarding the movement in the company's share price. In its response dated March 14, 2026, the company explicitly stated that there are no events, information, or developments that have a bearing on the operation or performance of the company, including any price-sensitive information that may result in the increase in share price.

Parameter:	Details
Response Date:	March 14, 2026
BSE Inquiry Reference:	L/SURV/ONL/PV/APJ/ 2025-2026 / 3431
Regulation:	SEBI (LODR) Regulations, 2015 - Regulation 30
Signatory:	Sreedhara Reddy Kanaparthy, Whole time Director

Company's Position on Price Movement

The company emphasized that no extraordinary events have taken place that would cause a rise in its share price. This clarification aligns with the requirements under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to disclose material events and information that could impact share prices.

Commitment to Future Disclosures

Gayatri BioOrganics assured the exchange that any material events arising in the future will be promptly communicated to BSE without fail. The clarification was digitally signed by Whole time Director Sreedhara Reddy Kanaparthy on March 14, 2026, demonstrating the company's commitment to maintaining transparency and regulatory compliance.

The company, headquartered in Hyderabad, Telangana, continues to maintain its obligations under SEBI regulations while ensuring proper communication with stock exchanges regarding any developments that may impact investor interests.